Kee Woong Kwon

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Heat Shock Protein

Atopic Dermatitis

Klebsiella Pneumoniae

Immune Response

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Kee Woong Kwon, Han-Gyu Choi, Kwang Sung Kim, Shin Ae Park, Hwa-Jung Kim, Sung Jae Shin
BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice. NPJ vaccines 9 (1) (2024)
Kee Woong Kwon, Han-Gyu Choi, Kwang Sung Kim, Shin Ae Park, Hwa-Jung Kim, Sung Jae Shin
BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice. NPJ vaccines 9 (1) (2024)
Kee Woong Kwon, Tae Gun Kang, Ara Lee, Seung Mo Jin, Yong Taik Lim, Sung Jae Shin, Sang-Jun Ha
Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection. Immune network 23 (2) (2023)
Kee Woong Kwon, Tae Gun Kang, Ara Lee, Seung Mo Jin, Yong Taik Lim, Sung Jae Shin, Sang-Jun Ha
Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection. Immune network 23 (2) (2023)
Kee Woong Kwon, Tae Gun Kang, Ara Lee, Seung Mo Jin, Yong Taik Lim, Sung Jae Shin, Sang-Jun Ha
Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection. Immune network 23 (2) (2023)
Lee-Han Kim, Soon Myung Kang, Jake Whang, Kee Woong Kwon, Sung Jae Shin
Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection. Antimicrobial agents and chemotherapy 66 (9) (2022)
Kee Woong Kwon, Lee-Han Kim, Soon Myung Kang, Ju Mi Lee, Eunsol Choi, Jiyun Park, Jung Joo Hong, Sung Jae Shin
Host-directed anti-mycobacterial activity of colchicine, an anti-gout drug, via strengthened host innate resistance reinforced by the IL-1β/PGE 2 axis. British journal of pharmacology 179 (15) (2022)
Yeeun Bak, Sang Chul Park, Dahee Shim, Yura Ha, Ju Mi Lee, Hongmin Kim, Kee Woong Kwon, Joo-Heon Yoon, Sung Jae Shin
Exacerbation of Mycobacterium avium pulmonary infection by comorbid allergic asthma is associated with diminished mycobacterium-specific Th17 responses. Virulence 12 (1) (2022)
Ju Mi Lee, Jiyun Park, Steven G Reed, Rhea N Coler, Jung Joo Hong, Lee-Han Kim, Wonsik Lee, Kee Woong Kwon, Sung Jae Shin
Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective as an adjunct to antibiotic treatment in chronic disease. Virulence 13 (1) (2022)
Tae Gun Kang, Kee Woong Kwon, Kyungsoo Kim, Hoyoung Lee, Myeong Joon Kim, Sang-Jun Ha, Sung Jae Shin
Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx. Nature communications 13 (1) (2022)
Han-Gyu Choi, Kee Woong Kwon, Seunga Choi, Yong Woo Back, Hye-Soo Park, Soon Myung Kang, Eunsol Choi, Sung Jae Shin, Hwa-Jung Kim
Antigen-Specific IFN-γ/IL-17-Co-Producing CD4+ T-Cells Are the Determinants for Protective Efficacy of Tuberculosis Subunit Vaccine. Vaccines 8 (2) (2020)